-
EP1268860
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1268860
| EP1268860 - PATIENT STRATIFICATION FOR CANCER THERAPY BASED ON GENOMIC DNA MICROARRAY ANALYSIS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 19.03.2010 Database last updated on 02.11.2024 | Most recent event Tooltip | 19.03.2010 | Application deemed to be withdrawn | published on 21.04.2010 [2010/16] | Applicant(s) | For all designated states Vysis, Inc. 3100 Woodcreek Drive Downers Grove, IL 60515-5400 / US | [2003/01] | Inventor(s) | 01 /
SEELIG, Steven, A. Apartment 119 19 Foxcroft Naperville, IL 60565 / US | [2003/01] | Representative(s) | Modiano, Micaela Nadia Modiano Josif Pisanty & Staub Ltd Thierschstrasse 11 80538 München / DE | [N/P] |
| Former [2005/45] | Modiano, Micaela Nadia Modiano, Josif, Pisanty & Staub Ltd., Baaderstrasse 3 80469 München / DE | ||
| Former [2003/01] | Modiano, Guido, Dr.-Ing., et al Modiano, Josif, Pisanty & Staub, Baaderstrasse 3 80469 München / DE | Application number, filing date | 01964688.4 | 29.03.2001 | [2003/01] | WO2001US10063 | Priority number, date | US20000539400 | 31.03.2000 Original published format: US 539400 | [2003/01] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO0175160 | Date: | 11.10.2001 | Language: | EN | [2001/41] | Type: | A1 Application with search report | No.: | EP1268860 | Date: | 02.01.2003 | Language: | EN | The application published by WIPO in one of the EPO official languages on 11.10.2001 takes the place of the publication of the European patent application. | [2003/01] | Search report(s) | International search report - published on: | US | 11.10.2001 | (Supplementary) European search report - dispatched on: | EP | 03.05.2007 | Classification | IPC: | C12Q1/68 | [2003/01] | CPC: |
C12Q1/6886 (EP,US);
C12Q1/6841 (US);
C12Q1/6837 (EP,US);
C12Q2600/106 (EP,US)
| Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2003/01] | Title | German: | PATIENTEN-STRATIFIZIERUNG IN DER KREBSTHERAPIE AUF DER BASIS VON DNA GENOM MIKROARRAY-ANALYSEN | [2003/01] | English: | PATIENT STRATIFICATION FOR CANCER THERAPY BASED ON GENOMIC DNA MICROARRAY ANALYSIS | [2003/01] | French: | STRATIFICATION DE PATIENTS A DES FINS DE THERAPIE DU CANCER SUR LA BASE DE L'ANALYSE DE MICRO-RESEAUX D'ADN GENOMIQUE | [2003/01] | Entry into regional phase | 30.09.2002 | National basic fee paid | 30.09.2002 | Search fee paid | 30.09.2002 | Designation fee(s) paid | 30.09.2002 | Examination fee paid | Examination procedure | 25.10.2001 | Request for preliminary examination filed International Preliminary Examining Authority: US | 30.09.2002 | Amendment by applicant (claims and/or description) | 30.09.2002 | Examination requested [2003/01] | 19.02.2008 | Despatch of a communication from the examining division (Time limit: M06) | 26.08.2008 | Reply to a communication from the examining division | 14.04.2009 | Despatch of a communication from the examining division (Time limit: M06) | 27.10.2009 | Application deemed to be withdrawn, date of legal effect [2010/16] | 01.12.2009 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2010/16] | Fees paid | Renewal fee | 24.03.2003 | Renewal fee patent year 03 | 04.03.2004 | Renewal fee patent year 04 | 04.03.2005 | Renewal fee patent year 05 | 06.03.2006 | Renewal fee patent year 06 | 05.03.2007 | Renewal fee patent year 07 | 10.03.2008 | Renewal fee patent year 08 | 06.03.2009 | Renewal fee patent year 09 | 08.03.2010 | Renewal fee patent year 10 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [ ] - No Search | International search | [AE]US6210878 (PINKEL DANIEL [US], et al) | Examination | WO9944062 | - SMOLEN GROMOSLAW A ET AL, "Amplification of MET may identify a subset of cancers with extreme sensitivity to the selective tyrosine kinase inhibitor PHA-665752", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE, WASHINGTON, DC.; US, (20060201), vol. 103, no. 7, pages 2316 - 2321, XP002392188 DOI: http://dx.doi.org/10.1073/pnas.0508776103 | - URL: http://www.devicelink.com/ivdt/archive/98/11/010.html | - JARVINEN T A H ET AL, "Predictive value of topoisomerase IIalpha and other prognostic factors for epirubicin chemotherapy in advanced breast cancer", BRITISH JOURNAL OF CANCER, (199806), vol. 77, no. 12, pages 2267 - 2273, XP009114360 | - DEFRANCESCO LAURA, "Fish or Chips", SCIENTIST, PHILADELPHA, PA, (19990301), vol. 13, no. 5, page 16, XP009114095 | - GOLUB T R ET AL, "Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE, US, WASHINGTON, DC, (19991015), vol. 286, no. 5439, pages 531 - 537, XP002207658 DOI: http://dx.doi.org/10.1126/science.286.5439.531 | - KLIJN J G M ET AL, "PROGNOSTIC FACTORS AND RESPONSE TO THERAPY IN BREAST CANCER", CANCER SURVEYS, OXFORD, GB, (19930101), vol. 18, pages 165 - 198, XP002207658 DOI: http://dx.doi.org/10.1126/science.286.5439.531 |